The Team Driving the Next Era of Precision Health

Thomas brings over 25 years of international experience focused on driving growth and innovation for software, data and services companies in the healthcare and life sciences space. Prior to DNAnexus, Thomas was EVP and President at Change Healthcare (NASDAQ: CHNG). Before that, Thomas was President of the global health sciences division at SAP. Previously, Thomas was CEO of Sutherland Healthcare Solutions, and he also worked at Cognizant, as Managing Director responsible for a portfolio of healthcare ventures. Thomas started his career at Deloitte Consulting, where he focused on strategy, transformation, and merger & acquisition programs for technology companies. He received his Master in Business Management degree from the ICHEC Brussels Management School in Brussels, Belgium.

Part of DNAnexus since its inception, George has been involved in the design and implementation of the DNAnexus product line and its application in key accounts around the world. George holds a PhD in computer science from Stanford University, where he helped analyze 1% of the human genome as part of the ENCODE Pilot Project. His prior research experience includes comparative metagenomics, silicon compilers for reconfigurable hardware, and elliptic curve cryptanalysis.

Jim serves as our Chief Financial Officer. Most recently, he was the CFO for Cumulus Networks (sold to NVIDIA). Prior to Cumulus, he held CFO roles at Panasas, VSS Network Monitoring, Solexant Corp, and Nanosolar. He entered the venture capital world after serving as the VP of Finance for 4 divisions of IBM (Hard Disk Drives, Storage Subsystems, Consumer Products Division, and Open System Servers & Software) as well as Hitachi Global Storage Technologies. Jim received a BS in Commerce & Engineering from Drexel University and an MBA from Stanford.

Kelly leads efforts in all things "people”. She is responsible for talent acquisition, employee growth and development, building a great culture, and facilitating organizational development. Kelly joined DNAnexus after leading HR at Telenav, another disruptive tech company in Silicon Valley. There, Kelly led the HR transition from venture-backed “start up” through a successful IPO. She holds a Bachelor's in Psychology from Stonehill College.

Bill Madigan is a tech-savvy leader firmly committed to entrepreneurship, innovation, and disrupting traditional healthcare markets.. With over 25 years of commercial and business leadership, Bill’s expertise spans all key healthcare sectors including Life Sciences, Payers and Providers.  Prior to joining DNAnexus, Bill served as Chief Revenue Officer (CRO) of  Komodo Health.  Prior to Komodo, Bill worked in leadership positions across UHG’s Optum as a Senior Director of Sales for Optum’s Life Sciences division and the US Head of Provider Analytics.  Bill obtained his Masters of Business Administration (MBA) from Northeastern University in Boston, MA.

Omar has decades of experience designing global cloud platforms pioneering the use of collaborative feedback networks to solve challenging information extraction problems. He is the Principal Architect of precisionFDA.gov, the FDA cloud platform that is transforming the regulatory research and review process for precision drugs and devices. Prior to DNAnexus, Omar managed operations for the AWS Elastic Compute Cloud when single regions were topping the one-million server mark. Previously, he led platforms for a Twitter search engine at Topsy Labs, and crowd-sourced messaging security at Cloudmark. Omar received his Bachelor of Science in Chemistry from UC Berkeley.

Dr. Jeff Keller is a proven innovator in biomedical research, commercial strategy, and early-stage technology development. He earned his doctorate in Cell and Developmental Biology from Vanderbilt University and completed advanced postdoctoral research at the Massachusetts Institute of Technology’s David H. Koch Center for Integrative Cancer Research.

Todd Oakland serves as our Senior Vice President and General Manager, Biopharma Rx/Dx. Prior to joining DNAnexus, he was Vice President and Product Lead for Precision Oncology at ConcertAI, where he led real-world data strategy and product development across pharmaceutical and diagnostics partnerships.

Before ConcertAI, Todd held multiple roles at Aitia, including Vice President of Customer Success and Executive Director of Real-World Evidence and Analytics, helping to advance the company’s causal AI platform for life sciences applications. He also spent time at Optum leading engagements on the RWE team, focusing on pharmaceutical clients with large-scale healthcare data and analytics.

Todd began his career in translational science and academia, with roles at the University of Chicago and Harvard T.H. Chan School of Public Health. He holds a Ph.D. in Virology from the University of Chicago, an M.P.H. in Quantitative Methods from the Harvard T.H. Chan School of Public Health, and a B.S. in Molecular Biology from Purdue University.

Kristy Cloyd-Warwick leads the Customer Experience organization at DNAnexus, ensuring that every customer achieves the scientific and clinical outcomes they expect. Reflecting DNAnexus’s investment in elite industry expertise, her organization spans Customer Success, DNAnexus Care (a 24/7 global scientific and technical support team), Technical Enablement, the DNAnexus Academy, and a world-class Professional Services division.

An accomplished scientific executive with over 15 years of experience scaling enterprise genomic and multi-omic data ecosystems, Kristy previously managed global bioinformatics and informatics organizations, including at QIAGEN. She holds a PhD in Biomedical Engineering and Biomaterials from Imperial College London, alongside a surgical device patent and multiple highly cited, peer-reviewed publications.